Resistance to MAPK Pathway Inhibition in BRAF-V600E Mutant Colorectal Cancer Can Be Overcome with Insulin Receptor/Insulin-like Growth Factor-1 Receptor Inhibitors
Layla El Bouazzaoui(Utrecht University), Onno Kranenburg(Utrecht University)
Cited by 0
Related Papers
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
|Frontiers in Immunology|2023|104
Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
|British Journal of Cancer|2010|26
Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737
|Cellular Oncology|2011|18